Back to top
China
Firm | Deal | Value | Client | Lawyer(s) involved |
Clifford Chance | JSC Altyn Bank sale of its 60% stake in JSC Halyk Bank to China CITIC Bank Corp | N/A | China CITIC Bank Corpo | Terence Foo (China co-managing partner)
Yufei Liao (Counsel)
Stacey Shen, Iris Liu (Associates) |
Back to top
Hong Kong
Firm | Deal | Value | Client | Lawyer(s) involved |
Wilson Sonsini Goodrich & Rosati | $511 million | WuXi Biologics |
| |
Fangda Partners | $511 million | WuXi Biologics |
| |
Shearman & Sterling | $511 million | Bank of America Merrill Lynch, Morgan Stanley, China Merchant Securities (underwriters) | Colin Law, Paloma Wang, Matthew Bersani, Laurence Crouch (Partners)
Maggie Guan (Counsel)
Arman Lie, Wanda Woo, Yuanjing Chen (Associates) | |
Jingtian & Gongcheng | $511 million | Bank of America Merrill Lynch, Morgan Stanley, China Merchant Securities (underwriters) |
| |
Maples and Calder | $511 million | WuXi Biologics | Derrick Kan (Partner) | |
Davis Polk & Wardwell | SOCAM Development’s high-yield notes offering
| $80 million | SOCAM Development | William F. Barron (Partner)
Gerhard Radtke, Alon Gurfinkel (Counsels)
Xuelin (Steve) Wang (Registered foreign lawyer)
Veronica Orecharova (Associate) |
Back to top
India
Firm | Deal | Value | Client | Lawyer(s) involved |
Squire Patton Boggs | State Bank of India’s Rule 144A qualified institutions placement | $ 2.3 billion | State Bank of India | Biswajit Chatterjee (Partner)
Kaustubh George (Senior associate)
Anandee Banerji, Gowri Reghuvaran (Associates) |
Cyril Amarchand Mangaldas | State Bank of India’s Rule 144A qualified institutions placement | $ 2.3 billion | State Bank of India | Gaurav Gupte (Partner)
Devaki Mankad (Principal Associate)
Akanksha Bapna (Associate) |
Allen & Overy | State Bank of India’s Rule 144A qualified institutions placement | $ 2.3 billion | Deutsche Equities India, DSP Merrill Lynch, IIFL Holdings, JM Financial Institutional Securities, Kotak Mahindra Capital, SBI Capital Markets (bookrunning lead managers) | Amit Singh (Partner)
David Cameron, Julie Song (Associates)
|
Shardul Amarchand Mangaldas | State Bank of India’s Rule 144A qualified institutions placement | $ 2.3 billion | Deutsche Equities India, DSP Merrill Lynch, IIFL Holdings, JM Financial Institutional Securities, Kotak Mahindra Capital, SBI Capital Markets (bookrunning lead managers) | Monal Mukherjee (Partner) Sagarnil Banerjee (Senior Associate)
Mubashshir Sarshar (Associate)
|
Luthra & Luthra | ICU Medical’s acquisition of Hospira’s infusion systems business | $900 million | ICU Medical | Dipti Lavya Swain (Partner)
Prateek Rastogi (Managing Associate)
Srabanee Ghosh (Associate) |
Back to top
Malaysia
Firm | Deal | Value | Client | Lawyer(s) involved |
Clifford Chance | $1.4 billion | Lotte Chemical Titan Holding |
| |
Adnan Sundra & Low | $1.4 billion | Lotte Chemical Titan Holding |
| |
Cleary Gottlieb Steen & Hamilton | $1.4 billion | Maybank Investment Bank, Credit Suisse, J.P. Morgan (joint global coordinators)
CIMB Investment Bank, HSBC, Nomura (joint bookrunners) |
| |
Kadir Andri & Partners | $1.4 billion | Maybank Investment Bank, Credit Suisse, J.P. Morgan (joint global coordinators)
CIMB Investment Bank, HSBC, Nomura (joint bookrunners) |
|